BTEC.L vs. BIOT.L
BTEC.L (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) and BIOT.L (L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF) are both Health & Biotech Equities funds - BTEC.L tracks the NASDAQ Biotechnology NET Index while BIOT.L tracks the Solactive Pharma Breakthrough Value Index Net Total Return. Both are passively managed. Over the past 5 years, BTEC.L returned 5.87%/yr vs 2.83%/yr for BIOT.L. Their correlation of 0.82 suggests significant overlap in exposure. BTEC.L charges 0.35%/yr vs 0.49%/yr for BIOT.L.
Performance
BTEC.L vs. BIOT.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BTEC.L achieves a 15.22% return, which is significantly higher than BIOT.L's 8.27% return.
BTEC.L
- 1D
- 0.68%
- 1M
- 9.55%
- 6M
- 13.18%
- YTD
- 15.22%
- 1Y
- 50.31%
- 3Y*
- 16.99%
- 5Y*
- 5.87%
- 10Y*
- —
BIOT.L
- 1D
- 0.31%
- 1M
- 7.79%
- 6M
- 7.56%
- YTD
- 8.27%
- 1Y
- 33.81%
- 3Y*
- 10.20%
- 5Y*
- 2.83%
- 10Y*
- —
BTEC.L vs. BIOT.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) | 15.22% | 32.96% | -2.04% | 6.22% | -11.92% | -0.49% | 27.40% | 25.57% | -13.84% |
BIOT.L L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF | 8.27% | 36.47% | -5.31% | -9.28% | -8.41% | -3.60% | 28.29% | 13.02% | -8.12% |
Correlation
The correlation between BTEC.L and BIOT.L is 0.88, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.88 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.83 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.83 |
Correlation (All Time) Calculated using the full available price history since Jan 18, 2018 | 0.82 |
The correlation between BTEC.L and BIOT.L has been stable across timeframes, ranging from 0.82 to 0.88 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BTEC.L vs. BIOT.L — Risk / Return Rank
BTEC.L
BIOT.L
BTEC.L vs. BIOT.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L) and L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF (BIOT.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BTEC.L | BIOT.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.75 | ||
| Sortino ratioReturn per unit of downside risk | +0.96 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.28 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 6.22 | 3.52 | +2.70 |
| Martin ratioReturn relative to average drawdown | 19.15 | 10.12 | +9.02 |
Loading charts...
Drawdowns
BTEC.L vs. BIOT.L - Drawdown Comparison
The maximum BTEC.L drawdown since its inception was -38.42%, which is greater than BIOT.L's maximum drawdown of -34.44%. Use the drawdown chart below to compare losses from any high point for BTEC.L and BIOT.L.
Loading charts...
Drawdown Indicators
| BTEC.L | BIOT.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.42% | -34.44% | -3.98% |
Max Drawdown (1Y)Largest decline over 1 year | -7.94% | -9.55% | +1.61% |
Max Drawdown (3Y)Largest decline over 3 years | -26.74% | -19.91% | -6.83% |
Max Drawdown (5Y)Largest decline over 5 years | -38.42% | -33.80% | -4.62% |
Current DrawdownCurrent decline from peak | -3.87% | -5.72% | +1.85% |
Average DrawdownAverage peak-to-trough decline | -13.22% | -13.31% | +0.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.58% | 3.33% | -0.75% |
Volatility
BTEC.L vs. BIOT.L - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L) and L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF (BIOT.L) have volatilities of 5.91% and 6.08%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BTEC.L | BIOT.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.91% | 6.08% | -0.17% |
Volatility (6M)Calculated over the trailing 6-month period | 15.67% | 15.54% | +0.13% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.42% | 20.18% | +0.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.39% | 18.62% | +2.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.37% | 19.50% | +2.87% |
BTEC.L vs. BIOT.L - Expense Ratio Comparison
BTEC.L has a 0.35% expense ratio, which is lower than BIOT.L's 0.49% expense ratio.
Dividends
BTEC.L vs. BIOT.L - Dividend Comparison
Neither BTEC.L nor BIOT.L has paid dividends to shareholders.
Frequently Asked Questions
BTEC.L and BIOT.L have a correlation of 0.88, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, BTEC.L is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
BTEC.L is cheaper with a 0.35% expense ratio, compared with 0.49% for BIOT.L.
BTEC.L tracks NASDAQ Biotechnology NET Index, while BIOT.L tracks Solactive Pharma Breakthrough Value Index Net Total Return. They also come from different issuers: iShares and L&G. Their fees differ too: 0.35% for BTEC.L and 0.49% for BIOT.L.
Find the right allocation for BTEC.L and BIOT.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer